MétaCan
Menu
Back to cohort
Record W2587660016 · doi:10.1093/ecco-jcc/jjx002.585

P460 Early use of therapeutic drug monitoring to individualize infliximab therapy in paediatric IBD: a multicentre prospective COHORT study

2017· article· en· W2587660016 on OpenAlexaffabout
Eileen Crowley, Nicholas Carman, Valerie Arpino, Karen Frost, Amanda Ricciuto, Mary Sherlock, Jeffrey Critch, David R. Mack, Eric I. Benchimol, Kevan Jacobson, Sally Lawrence, Jennifer deBruyn, A Otley, Hien Q. Huynh, Peter Church, Thomas D. Walters, A M Griffiths

Bibliographic record

VenueJournal of Crohn s and Colitis · 2017
Typearticle
Languageen
FieldImmunology and Microbiology
TopicImmunodeficiency and Autoimmune Disorders
Canadian institutionsUniversity of AlbertaUniversity of ManitobaAlberta Children's HospitalChildren's Hospital of Eastern OntarioDalhousie UniversityBC Children's HospitalJaneway Children's Health and Rehabilitation CentreMcMaster Children's HospitalHospital for Sick Children
Fundersnot available
KeywordsMedicineInfliximabTherapeutic drug monitoringProspective cohort studyDrugPharmacotherapyCohort studyPediatricsIntensive care medicineInternal medicinePharmacologyDisease

Abstract

fetched live from OpenAlex

Background: Therapeutic drug monitoring (TDM) during infliximab (ifx) maintenance therapy is regularly used in Canada to assess loss of response and to aid in dose optimization, with pre-infusion trough levels in the range of 5–10ug/ml recommended as targets. Levels achieved early following standard induction dosing among pediatric patients are highly variable, and often inadequate even at week 12. Limited data exist in adults or children concerning the role of TDM and target levels during induction. Within the Canadian children IBD Network, we proposed to measure ifx levels during induction, aiming to determine the optimal levels required to achieve target 5–10 ug/ml at the start of maintenance. Methods: Beginning in May 2016, children initiating ifx at SickKids Hospital and at other centres within the CIDsCANN inception cohort study had trough levels measured by ELISA at the time of the of final induction and first maintenance infusions (doses 3 and 4). Induction regimens were at the discretion of the treating physician, but often intensified among patients with severe UC. Influence of patient demographics and baseline disease activity (PGA, wPCDAI/PUCAI) on early trough levels were assessed. Results: From May to December 2016 at 9 participating sites, 66 children (median age 11.8 years, 53% male, 52% CD, 48% UC/IBD-U; IBD duration at start of biologic 4.3mos (IQR 14.02–13.02 mos). Induction regimen was “standard” (0, 2, 6 weeks) in 77% and intensified in 23% (O, 1, 4 weeks; all steroid refractory colitis). Table 1 gives characteristics of those receiving standard vs intensified regimens As shown in Table 1, IFX levels were highly variable prior to 3rd induction dose. Within the standard induction dosing cohort, the interval between dose 3 and 4 was shortened to 6 weeks in 50%. 41% attained targeted 5–10 dose 4 levels. Despite higher dosing per kg during induction and shorter interval prior to dose 4 in the intensified regimen, IFX levels at start of maintenance were comparable to patients receiving standard induction. Table 1. Basic demographic data Induction Infliximab TDM Study Conclusions: Variability in infliximab exposure is evident during induction. Adjusting dose intervals based on pre 3rd dose induction levels, increases the likelihood of entering maintenance dosing on target. An intensified regimen is necessary for patients with active colitis to achieve comparable post induction levels. The results suggest that the use of TDM during induction to individualize dosing more consistently ensures adequate drug exposure at start of maintenance.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.031
Threshold uncertainty score0.540

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.273
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2017
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Crohn s and ColitisSame topicImmunodeficiency and Autoimmune DisordersFrench-language works237,207